| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +25.00% | +1.43% | -0.08% | +1.51% | +1.58% | — |
| 14d | 4 | +25.00% | +1.91% | -0.70% | +2.61% | +3.07% | — |
| 30d | 4 | +75.00% | -4.02% | -5.42% | +1.40% | +0.68% | — |
| 60d | 4 | +100.00% | -7.65% | +2.40% | -10.05% | -10.73% | — |
| 90d | 4 | +100.00% | -7.10% | +7.85% | -13.97% | -15.26% | — |
| 180d | 4(4 pending) | — | — | — | — | — | — |
| 1y | 4(4 pending) | — | — | — | — | — | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 33 | $453.45 | $15.0K | 7,284 | May 15, 2026 | May 19, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 620 | $486.35 | $301.5K | 7,284 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Scientific Officer | 582 | $485.11 | $282.3K | 7,904 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 1,182 | $473.68 | $559.9K | 8,486 | Feb 18, 2026 | Feb 19, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Scientific Officer | 1,110 | $483.75 | $537.0K | 12,105 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 2,437 | $489.46 | $1.19M | 9,668 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | PURCHASEGRANT Stock grant | 2,584 | — | — | 13,215 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Scientific Officer | 2,283 | $487.76 | $1.11M | 10,631 | Feb 13, 2026 | Feb 18, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 2,021 | $460.43 | $930.5K | 12,914 | Feb 11, 2026 | Feb 12, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Scientific Officer | 1,127 | $468.41 | $527.9K | 14,935 | Feb 10, 2026 | Feb 12, 2026 ↗ | View → |